Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723423 · ClinicalTrials.gov registry record
Mastectomy Reconstruction Outcomes Consortium (MROC) Study
A clinical trial of Breast Cancer, sponsored by University of Michigan.
- Completed
- Registry status
- 4,436
- Enrollment target
- 11
- Study locations
NCT01723423: Completed study of Breast Cancer, sponsored by University of Michigan.
NCT01723423 is a study of Breast Cancer that has completed, run by University of Michigan. The registered enrollment target is 4,436 participants, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (58% higher). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01723423, a study of Breast Cancer, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 4,436 participants
- Enrollment target
- 11
- Study locations
Study Summary
The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many women choose reconstruction, the number of options as well as their pros and cons can make decision making difficult and stressful. From this research, we hope to learn more about what works best for patients undergoing these operations.
Primary Outcome
Patient reported outcome measures will include patient satisfaction, post-operative pain, body image, psycho-social functioning, physical functioning, and fatigue.
Conditions Studied
Study Locations (11)
Michigan
- University of Michigan Medical Center - Ann Arbor
- St. Joseph's Mercy Health System - Ann Arbor
District of Columbia
- Georgetown University Hospital - Washington D.C.
Georgia
- Georgia Institute for Plastic Surgery - Savannah
Illinois
- Northwestern Memorial Hospital - Chicago
Massachusetts
- Brigham and Women's Hospital - Boston
New York
- Memorial Sloan-Kettering Cancer Center - New York
Ohio
- Ohio State University Medical Center - Columbus
Texas
- M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,436 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-12 |
What the finished NCT01723423 record still lists
NCT01723423 is an observational study that tracks outcomes without assigning an intervention. Its 4,436 participants enrollment target places it among the larger protocols in the corpus, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (58% higher).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01723423 lists 11 locations in 10 states (Michigan, District of Columbia, Georgia).
Frequently Asked Questions
What is clinical trial NCT01723423 about?
NCT01723423 is a clinical study titled "Mastectomy Reconstruction Outcomes Consortium (MROC) Study". The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many...
What is the current status of trial NCT01723423?
This trial is currently completed. The enrollment target is 4,436 participants. The study started on 2011-08. Estimated completion is 2016-12.
What conditions does trial NCT01723423 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT01723423?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01723423 being conducted?
This trial has 11 study locations across District of Columbia, Georgia, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01723423's enrollment target sits among peer trials
4,436 32nd of 1224 higher than 1,193 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02660645 · 4,400 participants
Blue Light Cystoscopy With Cysview® Registry
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia